Skip to main navigation Skip to search Skip to main content

Safety and Immunogenicity Study of VLA15, A Multivalent Recombinant OSPA Based Vaccine CandidateAgainst Lyme Borrelioslis: A Randomized, Controlled, Observer-Blind Phase 2 Study in a Healthy Pediatric and Adult Study Population

SUNY Downstate Health Sciences University

Project: Research

Project Details

StatusFinished
Effective start/end date05/14/21 → 05/13/22

Funding

  • Valneva: $1,297.40